 |
|
Poll: Many parents, high-priority adults who tried to get H1N1 vaccine unable to get it
November 09, 2009Most who tried and didn't get it say they will try again
Boston, MA- A new national poll from Harvard School of Public Health (HSPH) researchers found that a majority of adults who tried to get the H1N1 vaccine for themselves or their children have been unable to do so. The poll, which examines the American public's response to the H1N1 vaccine shortage, is the fifth in a series of surveys of public views concerning the H1N1 flu outbreak undertaken by the Harvard Opinion Research Program at HSPH. The polling was done October 30 to November 1, 2009.
Challenges to Getting H1N1 Vaccine
VaccinationSince the H1N1 flu vaccine became available in October, 17% of American adults, 41% of parents, and 21% of high-priority adults have tried to get it. Among adults who tried to get it for themselves, 30% were able to get the vaccine and 70% were unable to get it. Among parents who tried to get the H1N1 vaccine for their children, 34% were able to get it and 66% were unable to get it. Among high priority adults who tried to get the H1N1 vaccine, 34% were able to get it and 66% were unable to get it.
Parents in this poll include those with children 6 months to less than 18 years. High-priority adults include adults who live with or care for a child less than 6 months of age, pregnant women, health care and emergency health personnel, and adults 25-64 with health conditions associated with higher risk of medical complications from influenza, such as asthma or heart disease.
The poll also shows that some people were not able to find information about the location of available H1N1 flu vaccine. Approximately half who tried to find such information (49%) were unable to find it.
"These findings suggest that the nationwide H1N1 vaccine shortage is presenting a real challenge for those who have tried to get the vaccine," said Robert J. Blendon, Professor of Health Policy and Political Analysis at HSPH, who co-directed the poll.
Personal Reactions to the Experience of Trying to Get H1N1 Vaccination
The poll suggests that nearly a third (29%) of those who have tried and could not get the vaccine (either for themselves or for their children) are very frustrated. That said, most who have tried and not been able to get it yet (91%) say they will try again this year to get the vaccine for themselves, their children or both.
"Public health officials who are encouraging H1N1 vaccination may be relieved to see that most people who have so far been unable to get the vaccine say they will try again," said Blendon.
Response to H1N1 Vaccine Shortage Overall
Looking more broadly at the issue of vaccine shortages, most Americans (82%) believe there is a shortage of H1N1 vaccine in the United States, and approximately 4 in 10 (41%) believe this is a major problem for the country. More than half of adults (60%) believe there is a shortage of H1N1 vaccine in their community.
Forty percent believe there will still not be enough H1N1 flu vaccine by the end of November for everyone in their community who wants it. Nearly a quarter (24%) say it will be a very serious problem for them and their immediate family if the H1N1 vaccine is not available by then.
This is the fifth in a series of surveys of public views concerning the H1N1 flu outbreak undertaken by the Harvard Opinion Research Program (HORP) at HSPH. See below:
"Survey Finds Nearly Half of Americans Concerned They Or Their Family May Get Sick from Swine Flu," May 1, 2009.
"Survey Finds Many Americans Have Taken Steps to Protect Themselves Against H1N1," May 8, 2009
"National Survey Finds Six in Ten Americans Believe Serious Outbreak of Influenza A (H1N1) Likely in Fall/Winter," July 15, 2009
"Survey Finds Just 40% of Adults Absolutely Certain They Will Get H1N1 Vaccine," October 2, 2009
Another survey from HORP looked at business preparedness:
"Four-Fifths of Businesses Foresee Severe Problems Maintaining Operations If Significant H1N1 Flu Outbreak," September 9, 2009
Methodology
This poll is part of an on-going series of surveys focused on the public and biological security by the Harvard Opinion Research Program (HORP) at Harvard School of Public Health. The study was designed and analyzed by researchers at the Harvard School of Public Health (HSPH). The project director is Robert J. Blendon of the Harvard School of Public Health. The research team also includes Gillian K. SteelFisher, John M. Benson, and Mark M. Bekheit of the Harvard School of Public Health, and Melissa J. Herrmann of SSRS/ICR. Fieldwork was conducted via telephone (including both landline and cell phone) for HORP by SSRS/ICR of Media (PA) October 30-November 1, 2009.
The survey was conducted with a representative national sample of 1,073 adults age 18 and over, including oversamples of non-Hispanic African Americans and Hispanics. Altogether, 107 non-Hispanic African Americans and 141 Hispanics were interviewed. In the overall results, these groups were weighted to their actual proportion of the total adult population.
The margin of error for the total sample is plus or minus 3.8 percentage points. Possible sources of non-sampling error include non-response bias, as well as question wording and ordering effects. Non-response in telephone surveys produces some known biases in survey-derived estimates because participation tends to vary for different subgroups of the population. To compensate for these known biases, sample data are weighted to the most recent Census data available from the Current Population Survey for gender, age, race, education, region, and number of adults in the household. Other techniques, including random-digit dialing, replicate subsamples, and systematic respondent selection within households, are used to ensure that the sample is representative.
Harvard School of Public Health
VaccinationSince the H1N1 flu vaccine became available in October, 17% of American adults, 41% of parents, and 21% of high-priority adults have tried to get it. Among adults who tried to get it for themselves, 30% were able to get the vaccine and 70% were unable to get it. Among parents who tried to get the H1N1 vaccine for their children, 34% were able to get it and 66% were unable to get it. Among high priority adults who tried to get the H1N1 vaccine, 34% were able to get it and 66% were unable to get it.
Parents in this poll include those with children 6 months to less than 18 years. High-priority adults include adults who live with or care for a child less than 6 months of age, pregnant women, health care and emergency health personnel, and adults 25-64 with health conditions associated with higher risk of medical complications from influenza, such as asthma or heart disease.
The poll also shows that some people were not able to find information about the location of available H1N1 flu vaccine. Approximately half who tried to find such information (49%) were unable to find it.
"These findings suggest that the nationwide H1N1 vaccine shortage is presenting a real challenge for those who have tried to get the vaccine," said Robert J. Blendon, Professor of Health Policy and Political Analysis at HSPH, who co-directed the poll.
Personal Reactions to the Experience of Trying to Get H1N1 Vaccination
The poll suggests that nearly a third (29%) of those who have tried and could not get the vaccine (either for themselves or for their children) are very frustrated. That said, most who have tried and not been able to get it yet (91%) say they will try again this year to get the vaccine for themselves, their children or both.
"Public health officials who are encouraging H1N1 vaccination may be relieved to see that most people who have so far been unable to get the vaccine say they will try again," said Blendon.
Response to H1N1 Vaccine Shortage Overall
Looking more broadly at the issue of vaccine shortages, most Americans (82%) believe there is a shortage of H1N1 vaccine in the United States, and approximately 4 in 10 (41%) believe this is a major problem for the country. More than half of adults (60%) believe there is a shortage of H1N1 vaccine in their community.
Forty percent believe there will still not be enough H1N1 flu vaccine by the end of November for everyone in their community who wants it. Nearly a quarter (24%) say it will be a very serious problem for them and their immediate family if the H1N1 vaccine is not available by then.
This is the fifth in a series of surveys of public views concerning the H1N1 flu outbreak undertaken by the Harvard Opinion Research Program (HORP) at HSPH. See below:
"Survey Finds Nearly Half of Americans Concerned They Or Their Family May Get Sick from Swine Flu," May 1, 2009.
"Survey Finds Many Americans Have Taken Steps to Protect Themselves Against H1N1," May 8, 2009
"National Survey Finds Six in Ten Americans Believe Serious Outbreak of Influenza A (H1N1) Likely in Fall/Winter," July 15, 2009
"Survey Finds Just 40% of Adults Absolutely Certain They Will Get H1N1 Vaccine," October 2, 2009
Another survey from HORP looked at business preparedness:
"Four-Fifths of Businesses Foresee Severe Problems Maintaining Operations If Significant H1N1 Flu Outbreak," September 9, 2009
Methodology
This poll is part of an on-going series of surveys focused on the public and biological security by the Harvard Opinion Research Program (HORP) at Harvard School of Public Health. The study was designed and analyzed by researchers at the Harvard School of Public Health (HSPH). The project director is Robert J. Blendon of the Harvard School of Public Health. The research team also includes Gillian K. SteelFisher, John M. Benson, and Mark M. Bekheit of the Harvard School of Public Health, and Melissa J. Herrmann of SSRS/ICR. Fieldwork was conducted via telephone (including both landline and cell phone) for HORP by SSRS/ICR of Media (PA) October 30-November 1, 2009.
The survey was conducted with a representative national sample of 1,073 adults age 18 and over, including oversamples of non-Hispanic African Americans and Hispanics. Altogether, 107 non-Hispanic African Americans and 141 Hispanics were interviewed. In the overall results, these groups were weighted to their actual proportion of the total adult population.
The margin of error for the total sample is plus or minus 3.8 percentage points. Possible sources of non-sampling error include non-response bias, as well as question wording and ordering effects. Non-response in telephone surveys produces some known biases in survey-derived estimates because participation tends to vary for different subgroups of the population. To compensate for these known biases, sample data are weighted to the most recent Census data available from the Current Population Survey for gender, age, race, education, region, and number of adults in the household. Other techniques, including random-digit dialing, replicate subsamples, and systematic respondent selection within households, are used to ensure that the sample is representative.
Harvard School of Public Health
H1N1 Vaccine Current Events and H1N1 Vaccine News RSSLessons from flu seasons past
Pregnant women who catch the flu are at serious risk for flu-related complications, including death, and that risk far outweighs the risk of possible side effects from injectable vaccines containing killed virus, according to an extensive review of published research and data from previous flu seasons.
NIH prepares to launch 2009 H1N1 influenza vaccine trial in people with asthma
The National Institutes of Health is preparing to launch the first government-sponsored clinical trial to determine what dose of the 2009 H1N1 influenza vaccine is needed to induce a protective immune response in people with asthma, especially those with severe disease.
Survey finds just 40 percent of adults 'absolutely certain' they will get H1N1 vaccine
In a new survey, Harvard School of Public Health (HSPH) researchers found that just 40% of adults are "absolutely certain" they will get the H1N1 vaccine for themselves, and 51% of parents are "absolutely certain" that they will get the vaccine for their children.
Most would refuse emergency use H1N1 vaccine or additive
A majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study.
Medical ethics experts identify, address key issues in H1N1 pandemic
The anticipated onset of a second wave of the H1N1 influenza pandemic could present a host of thorny medical ethics issues best considered well in advance, according to the University of Toronto Joint Centre for Bioethics, which today released nine papers for public discussion.
Rice researchers seek better vaccine procedure
As manufacturers work furiously to make a vaccine to protect against 2009 influenza A (H1N1) virus, a Rice University bioengineer is trying to improve the process for future flu seasons. The goal is to shorten the time it takes to identify targeted flu strains and manufacture the vaccines for them.
NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidates
Scientists in a network of medical research institutions across the United States are set to begin a series of clinical trials to gather critical data about influenza vaccines, including two candidate H1N1 flu vaccines.
More H1N1 Vaccine Current Events and H1N1 Vaccine News Articles
 |
60 Minutes - H1N1 (November 1, 2009) Airdate 11/01/09 Where is the vaccine that was supposed to save the nation from the H1N1 virus? Almost 100 people have died from the virus, hospitalizations are on the rise, but the vaccine is still in short supply. Health and Human Services Secretary Kathleen Sebelius tells Scott Pelley that it won't be long before everyone who wants the vaccine will get the vaccine, and she says it is safe and effective. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Sovereign Silver 2 oz Fine Mist Spray by Natural Immunogenics Benefits of Sovereign Silver Bio-Active Silver Hydrosol- To support your immune system for all of its needs, choose Sovereign Silver Bio Active Hydrosol the #1 Selling silver supplement in America.* It has a unique combination of five benefits no other manufacturer can match: 1. Actively Charged (Bio-Active) 2. Easily Absorbed 3. Less Is More 4. Perfectly Safe. 5. 99.999% PURE |
|
Pandemic influenza A (H1N1) vaccines, antivirals.(DRUGS, PREGNANCY, AND LACTATION): An article from: OB GYN News by Christina Chambers (Author) This digital document is an article from OB GYN News, published by International Medical News Group on October 1, 2009. The length of the article is 812 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Pandemic influenza A (H1N1) vaccines, antivirals.(DRUGS, PREGNANCY, AND LACTATION) Author: Christina Chambers Publication: OB GYN News (Magazine/Journal) Date: October 1, 2009 Publisher: International Medical News Group Volume: 44 Issue: 12 Page: 20(1) Distributed by Gale, a part of Cengage... | |
 |
40 Count Box of N95 Niosh Rated Respirators CDC Recommended for H1N1 Swine Flu Masks by MCS Online Keep yourself safe with this kit of 40 N95 Rated Niosh Respirators! |
 |
Warning Swine Flu Test Subject Keep Back Sign Logo Men's Tee Short Sleeve Size XL White by 99 Volts |
|
ACIP picks five groups for novel H1N1 vaccine; children are one of the priority groups.(INFECTIOUS DISEASE): An article from: Pediatric News by Miriam E. Tucker (Author) This digital document is an article from Pediatric News, published by International Medical News Group on August 1, 2009. The length of the article is 790 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: ACIP picks five groups for novel H1N1 vaccine; children are one of the priority groups.(INFECTIOUS DISEASE) Author: Miriam E. Tucker Publication: Pediatric News (Magazine/Journal) Date: August 1, 2009 Publisher: International Medical News Group Volume: 43 Issue: 8 Page: 1(2) Distributed by Gale, a part of Cengage... | |
 |
60 Minutes - H1N1 (October 18, 2009) Airdate 10/18/09 The H1N1 virus is already setting infection records in this country, and while most people who get this flu can handle it, in some cases, H1N1 can be deadly. Scott Pelley follows the case of 15-year-old Luke Duvall, a high school athlete in intensive care in Little Rock, Arkansas. With staphylococcal pneumonia on top of the H1N1, Luke is on a respirator and fighting for his life. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Individual H1N1 Swine Flu Kit Recommended by CDC for Prevention by MCS Online Keep yourself safe this year with the cheapest kit on the market. Kit contains: 1 N95 Niosh Rated Respirator, 1 Bottle of 2 oz Purell, 10 Purell Deep Hand Sanitizing Wipes, 1 Pair of Nitrile Medical Grade Protective Gloves. |
|
H1N1 vaccine will be available early this month.(NEWS): An article from: Skin & Allergy News by Mitchel L. Zoler (Author) This digital document is an article from Skin & Allergy News, published by International Medical News Group on October 1, 2009. The length of the article is 608 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: H1N1 vaccine will be available early this month.(NEWS) Author: Mitchel L. Zoler Publication: Skin & Allergy News (Magazine/Journal) Date: October 1, 2009 Publisher: International Medical News Group Volume: 40 Issue: 10 Page: 4(1) Distributed by Gale, a part of Cengage... | |
 |
Warning Swine Flu Test Subject Keep Back Sign Logo Men's Hoodie Sweat Shirt White XL by 99 Volts |
| © 2009 BrightSurf.com |